TITLE

Benefits of luteinizing hormone activity in ovarian stimulation for IVF

AUTHOR(S)
Venetis, C. A; Kolibianakis, E. M.; Tarlatzi, T. B.; Tarlatzis, B. C.
PUB. DATE
April 2009
SOURCE
Reproductive BioMedicine Online (Reproductive Healthcare Limited;2009 Supplement 2, Vol. 18 Issue S2, pS31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Knowledge of the physiology of folliculogenesis has led to a better understanding of the role of LH activity in this process. This role has been investigated in the setting of ovarian stimulation and several treatment modalities have been proposed. LH activity can be provided in the forms of: (i) human menopausal gonadotrophins (HMG), (ii) recombinant LH (rLH), (iii) human chorionic gonadotrophin (HCG), and (iv) recombinant HCG (rHCG). Current evidence suggests that ovarian stimulation performed with HMG in patients treated with a long gonadotrophin releasing hormone (GnRH) agonist protocol seems to result in increased (3-4%) clinical pregnancy rates compared with recombinant FSH (rFSH). Data regarding the short GnRH agonist or GnRH antagonist protocol are scarce and firm conclusions cannot be drawn. Administration of rLH prior or during ovarian stimulation with rFSH does not seem to increase the probability of pregnancy. Existing data suggest that HCG is capable of partially or completely replacing FSH administration during the mid-to-late follicular phase of an ovarian stimulation cycle, leading to a decreased requirement for FSH, without compromising pregnancy rates. High quality evidence originating from randomized controlled trials regarding the potential value of rHCG administration during ovarian stimulation for IVF is not available.
ACCESSION #
42633303

 

Related Articles

  • An OHSS-Free Clinic by segmentation of IVF treatment. Devroey, Paul; Polyzos, Nikolaos P.; Blockeel, Christophe // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2593 

    Published data indicate a significant increase in ovarian hyperstimulation syndrome globally. The occurrence of approximately three maternal deaths per 100 000 stimulated women has been reported, and extrapolation of these figures to a global situation would give an impressive number. The...

  • Early Cleavage of Zygote Not Accurate in Predicting Embryo Implantation Potential.  // Fertility Weekly;8/10/2009, p9 

    The article reports on the results of a study led by Wen-Jui Yang in Taiwan to test whether early cleavage was a strong indicator of pregnancy in patients undergoing either a GnRH agonists protocol or antagonist protocol for in vitro fertilization (IVF) and ICSI. The study includes 534 patients...

  • SELECTED ORAL COMMUNICATION SESSION, SESSION 33: AGONISTS AND ANTAGONISTS, Tuesday 5 July 2011 10:00 – 11:30.  // Human Reproduction;Jan2011 Supplement 1, Vol. 26 Issue suppl_1, pi46 

    No abstract available.

  • Duration of Stimulation is Shorter with GnRH Antagonist for Poor Responders.  // Fertility Weekly;2/20/2012, p8 

    The article reports on the study conducted by D. Pu and colleagues which evaluates the efficacy of luteinizing hormone releasing hormone antagonist (GnRH-ant) versus GnRh agonist (GnRH-a) protocols for ovarian stimulation in poor responders of in vitro fertilization (IVF). The researchers...

  • Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. D. Bodri; V. Vernaeve; J.J. Guillén; R. Vidal; F. Figueras; O. Coll // Human Reproduction;Sep2006, Vol. 21 Issue 9, p2246 

    BACKGROUND: Little information is available on the outcome of controlled ovarian hyperstimulation (COH) using GnRH antagonist in oocyte donation cycles especially in comparison with the short GnRH agonist protocol. This study was aimed at comparing the two stimulation protocols in oocyte...

  • GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran. Tebraninejad, Ensieh; Ghahghaei Nezamabadi, Akrain; Rashidi, Balool; Sohrabi, Maryam; Bagheri, Maiyam; Haghollahi, Fedyeh; Nekoo, Elham Azimi; Jafarabadi, Mina // Iranian Journal of Reproductive Medicine;Summer2011, Vol. 9 Issue 3, p171 

    Background: General concern is that the pregnancy rate is higher with GnRH-agonist as a protocol of pituitary suppression. GnRH-antagonist protocol provides a shorter period of administration and an easy flexible protocol. Objective: In this study, the outcomes of GnRH agonist and antagonist in...

  • GnRH agonist ovulation trigger and hCG-based, progesterone-free luteal support: a proof of concept study. Kol, Shahar; Humaidan, Peter; Itskovitz-Eldor, Joseph // Human Reproduction;Oct2011, Vol. 26 Issue 10, p2874 

    BACKGROUND It is now well established that a GnRH agonist (GnRHa) ovulation trigger completely prevents ovarian hyperstimulation syndrome. However, early studies, using conventional luteal support, showed inferior clinical results following a GnRHa trigger compared with a conventional hCG...

  • GnRH antagonist ganirelix prevents premature luteinization in IUI cycles: rationale for its use. Martinez-Salazar, Javier; Cerrillo, M.; Quea, G.; Pacheco, A.; Garcia-Velasco, J. A. // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Aug2009, Vol. 19 Issue 2, p156 

    This study evaluated the efficacy of a gonadotrophin-releasing hormone antagonist (GnRHa) to prevent premature luteinization (PL) and examined its impact on intrauterine insemination (IUI) cycle outcome. A total of 662 patients who were undergoing IUI were evaluated. Ovarian stimulation was...

  • The role of GnRH antagonists in assisted reproduction. Barri, Pedro N.; Martinez, Francisca; Coroleu, Buenaventura; Tur, Rosa // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Nov2002 Supplement 1, Vol. 5 Issue S1, p14 

    The different schemes of application of gonadotrophin-releasing hormone (GnRH) antagonists in ovarian stimulation protocols for assisted reproduction are reviewed. Starting from the initial schemes of single and/or multiple doses, the efficacy of GnRH antagonists in 'soft' protocols of ovarian...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics